Adjuvant antiviral therapy for the prevention of hepatocellular carcinoma recurrence after liver resection: indicated for all patients with chronic hepatitis B?

Affiliations

Editorial

Clifford Akateh et al. Ann Transl Med. 2018 Oct.

. 2018 Oct;6(20):397.

doi: 10.21037/atm.2018.08.20.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels: A Randomized Controlled Trial.
Huang G, Li PP, Lau WY, Pan ZY, Zhao LH, Wang ZG, Wang MC, Zhou WP. Huang G, et al. Ann Surg. 2018 Dec;268(6):943-954. doi: 10.1097/SLA.0000000000002727. Ann Surg. 2018. PMID: 29521740 Clinical Trial.

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86. 10.1002/ijc.29210 - DOI - PubMed
1. El-Serag HB, Kanwal F. Epidemiology of Hepatocellular Carcinoma in the United States: Where Are We? Where Do We Go? Hepatology 2014;60:1767-75. 10.1002/hep.27222 - DOI - PMC - PubMed
1. Global Burden of Disease Liver Cancer Collaboration , Akinyemiju T, Abera S, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: Results from the global burden of disease study 2015. JAMA Oncol 2017;3:1683-91. 10.1001/jamaoncol.2017.3055 - DOI - PMC - PubMed
1. Maucort-Boulch D, de Martel C, Franceschi S, et al. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int J Cancer 2018;142:2471-7. 10.1002/ijc.31280 - DOI - PubMed
1. Hung IF, Poon RT, Lai CL, et al. Recurrence of Hepatitis B-Related Hepatocellular Carcinoma Is Associated With High Viral Load at the Time of Resection. Am J Gastroenterol 2008;103:1663. 10.1111/j.1572-0241.2008.01872.x - DOI - PubMed